Italfarmaco: all 51 studies
Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Effect of the Dietary Supplement to Alleviate Dry Mouth.Not yet recruitingNCT07847840Not applicable
- Evaluation of the Mouthwash Effect on Maintaining Healthy Microbiome in Healthy Mouth.Not yet recruitingNCT07844993Not applicable
- Evaluation of the Dietary Supplement Effect on Improvement of Hair Condition in Subjects With Occasional Hair Loss.Not yet recruitingNCT07835646Not applicable
- Evaluation of the Effect of Combined Use of Cosmetic Products for Dry and Itchy Skin.Not yet recruitingNCT07695805Not applicable
- Evaluation of the Effect of the Toothpaste on Delicate GumsRecruitingNCT07494747Not applicable
- A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular DystrophyRecruitingNCT07127978
- Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years OldRecruitingNCT06769633Phase 2
- Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia VeraRecruitingNCT06093672Phase 3
- A Multicentre, Prospective, Open-label, Non-comparative StudyRecruitingNCT06067256Phase 4
- Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular DystrophyRecruitingNCT05933057Phase 3
- Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability StudyRecruitingNCT03373968Phase 2/3
- Pharmacokinetics, Safety and Tolerability of ITF2357 in Participants With Chronic Hepatic Impairment and With Normal Hepatic FunctionCompletedNCT06736223Phase 1Results posted
- Givinostat and Metabolites Pharmacokinetics in Urine and Plasma (Part 3)CompletedNCT05860114Phase 1Results posted
- The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2)CompletedNCT05845567Phase 1Results posted
- Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp ActivityCompletedNCT05492318Phase 1Results posted
- Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC IntervalCompletedNCT04821063Phase 1Results posted
- Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.CompletedNCT04574999Phase 3Results posted
- Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular DystrophyCompletedNCT03238235Phase 2Results posted
- Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular DystrophyCompletedNCT02851797Phase 3Results posted
- A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia VeraCompletedNCT01901432Phase 1/2Results posted
- A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMDCompletedNCT01761292Phase 1/2Results posted
- Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic ArthritisTerminatedNCT01557452Not applicableResults posted
- Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic ArthritisTerminatedNCT01261624Phase 2Results posted
- Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia VeraCompletedNCT00928707Phase 2Results posted
- Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's DiseaseTerminatedNCT00792740Phase 1/2Results posted
- Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's LymphomaCompletedNCT00792467Phase 1/2Results posted
- Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative DiseasesCompletedNCT00606307Phase 2Results posted
- Open Label, Multicentre Trial to Assess Safety and Efficacy of ITF2357 in Active Systemic Juvenile Idiopathic ArthritisCompletedNCT00570661Phase 2Results posted
- Evaluation of the Effect of the Gel on Sensitive TeethCompletedNCT07596797Not applicable
- Evaluation of Toothpaste Effect in Volunteers With Dental SensitivityCompletedNCT07593755Not applicable
- Evaluation of the Effect of the Mouthwash on Delicate GumsCompletedNCT07551908Not applicable
- Evaluation of the Whitening Effect in Subjects After Professional Tooth Cleaning ProcedureCompletedNCT07438990Not applicable
- Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss.CompletedNCT07433933
- Evaluation of Hydrating Cream Effect on Subjects With Dry Skin.CompletedNCT07393191Not applicable
- Evaluation of Mouthwash Use in Hygiene and Recovery After Interventions in GumsCompletedNCT07385586Not applicable
- Multicenter Prospective Real-world Observational Study to Evaluate the Effectiveness of Phlebotonics, as Conservative Therapy in a Cohort of Patients With Symptomatic Hemorrhoidal Disease (HD) of I, II or III Goligher GradeCompletedNCT07376928
- Evaluation of the Dietary Supplement Efficacy Against Hair Loss in Subjects Suffering From Hair LossCompletedNCT07358403Not applicable
- Prevalence And Burden Of Nausea And Vomiting In Pregnant WomenStatus unknownNCT04926727
- Post Marketing Follow Up Study To Evaluate Performance Safety Quality of Menopausal Transition Women Treated With AinaraCompletedNCT04362371Not applicable
- Open Non-Comparative Study To Evaluate Administration Of a New NutraceuticalCompletedNCT04245761Not applicable
- Open Non-Comparative Clinical Trial Study To Evaluate The Performance And Safety Of Ainara®CompletedNCT04245358Not applicable
- Clinical Trial Study To Evaluate The Performance And Safety Of Ainara®CompletedNCT04245293Not applicable
- Phase II Study With ITF2984 in Acromegalic PatientsCompletedNCT02111044Phase 2
- Interest of Intravaginal Electro-stimulation at Home by GYNEFFIK® Compared to Usual Care in Incontinent Patients With Prior Perineal ReeducationStatus unknownNCT02029027Phase 4
- A Two Part Phase 1, Repeated Doses and Continuous Infusion Study With ITF2984 in Healthy VolunteersCompletedNCT01897844Phase 1
- ITF2984 Repeated Doses Study in Healthy VolunteersCompletedNCT01871844Phase 1
- Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative NeoplasmsActive, not recruitingNCT01761968Phase 2
- Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)CompletedNCT00951574Phase 3
- Phase II Study of Histone-deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic LeukemiaTerminatedNCT00792831Phase 2
- Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple MyelomaTerminatedNCT00792506Phase 2
- phII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma PatientsTerminatedNCT00496431Phase 1/2